Clinical Trials Logo

Elevated Blood Pressure clinical trials

View clinical trials related to Elevated Blood Pressure.

Filter by:

NCT ID: NCT06413251 Completed - Hypertension Clinical Trials

Clinical Effectiveness of Boxing Training in Individuals With Elevated Blood Pressure or Stage 1 Hypertension

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to determine whether boxing training reduces cardiovascular risk in elevated blood pressure or hypertension stage 1 individuals. The main questions it aims to answer are (1) if boxing training reduces peripheral and central blood pressure and (2) if boxing training improves cardiovascular function in elevated blood pressure or hypertension stage 1 individuals. Participants with elevated blood pressure or hypertension stage 1 will be randomly divided into a control group or an intervention group. The latter group will be involved in boxing training, 3 days per week for 6 weeks. Researchers will compare clinical and cardiovascular outcomes between the control and the intervention group.

NCT ID: NCT06376812 Not yet recruiting - Clinical trials for Elevated Blood Pressure

No Time to Pause: Physical Activity to Improve Health of Midlife Hispanic Women

Start date: May 2026
Phase: N/A
Study type: Interventional

This study will test the effects of a physical activity intervention among midlife Hispanic women.

NCT ID: NCT06348225 Not yet recruiting - Clinical trials for Elevated Blood Pressure

Post-exercise Hot Water Immersion to Improve Overnight Blood Pressure

ExHT
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test whether putting your legs in a hot bath after exercise improves blood pressure in people with higher blood pressure. . The main questions it aims to answer are: - Whether exercise alone, hot water leg bath alone, or both treatments together cause blood pressure to be lower during sleep. - If there are any changes in heart rhythm or blood vessel health after exercise, hot water leg bath, or the two treatments together that relate to changes in blood pressure. Participants will complete four different trials: - 30 minutes of walking with a 45-minute lukewarm leg bath after - 30 minutes of walking with a 45-minute hot leg bath after - 45 minutes of a hot leg bath with no exercise - A day with no exercise or leg bath Researchers will look at their heart rhythm, blood vessels, and blood pressure after each of these trials to see if there are differences, and if exercise and heat together can improve heart health more than exercise or heat alone.

NCT ID: NCT06033417 Enrolling by invitation - Physical Inactivity Clinical Trials

Walking and Blood Pressure in Older Adults With Respiratory Impairment.

Start date: September 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of an 8-week walking program on blood pressure in inactive older adults with respiratory impairment, a condition where lung function is sub-optimal for a person's age. Older adults with respiratory impairment have greater risks of death by cardiovascular disease (CVD) compared to those without respiratory impairment, and this may be partly driven by higher resting blood pressure. One way to lower blood pressure is to increase the number of daily steps achieved throughout the course of everyday life ('lifestyle steps'), and previous research shows that an additional 3,000 lifestyle steps/day is effective for achieving this. However, whether an increase in daily lifestyle steps is effective for reducing blood pressure in senior-community dwelling older adults with respiratory impairment is unknown. Understanding how increasing daily steps impacts blood pressure in this understudied population is important for informing future strategies for tackling cardiovascular disease risk in those with lung dysfunction.

NCT ID: NCT05955040 Recruiting - Clinical trials for Elevated Blood Pressure

Treatment of Elevated Blood Pressures in Early Pregnancy

Start date: July 11, 2023
Phase: Phase 2
Study type: Interventional

This is a randomized controlled trial comparing the outcomes of treatment and non-treatment of elevated blood pressures in early pregnancy.

NCT ID: NCT05928676 Completed - Hypertension Clinical Trials

Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure

Start date: June 24, 2023
Phase: N/A
Study type: Interventional

Conversion of dietary nitrates to nitric oxide (NO) is a non-canonical pathway that plays an important role in NO biology, particulalry under pathological conditions. Nitrate supplementation has been shown to help control mild hypertension. Recent studies have suggested that another gaseous transmitter, hydrogen sulfide, also influences NO biosynthesis and metabolism. This open-label clinical trial will evalute the effect of Vascanox® HP, a proprietary formulation that combines dietary sources of nitric oxide and hydrogen sulfide, on nitric oxide bioavailability and on blood pressure in subjects experiencing elevated blood pressure. Participants will supplement with Vascanox® HP for four weeks. Blood pressure will be measured at baseline, two weeks, and fours weeks. Salivary nitric oxide will be assessed prior to and two, six, and 24 hours after dosing on the first day of the study and prior to and two hours after dosing at subsequent study visits. Participants will also self-monitor their saliva nitric oxide levels and blood pressure daily for 4 weeks. Changes in study outcomes over time will be evaluated via analysis of variance (ANOVA) and paired t-tests.

NCT ID: NCT05533268 Completed - Clinical trials for Elevated Blood Pressure

Effect of Mental and Physical Training on Blood Pressure

Start date: October 25, 2022
Phase: N/A
Study type: Interventional

Elevated blood pressure or prehypertension is highly associated with increased risk of developing hypertension, cardiovascular event, and type II diabetes. Many physically inactive young adults, particularly in Malaysia have blood pressure higher than normal range, therefore it is important to control the blood pressure within normal range as prophylactic measure. This experimental research will be carried out to study the effect of physical training (aerobic exercise) and mental training (mindfulness meditation) with diet as a control group on the systolic blood pressure, diastolic blood pressure and resting heart rate among young adult with elevated blood pressure living a sedentary lifestyle. Participant will be divided into 2 experimental groups (mental and physical training) and 1 control group (Dietary Approaches to Stop Hypertension -DASH diet plan) who need to complete the prescribed intervention for 6 weeks. Results will be analysed by repeated measures ANOVA followed by post-hic test.

NCT ID: NCT05469503 Active, not recruiting - Metabolic Syndrome Clinical Trials

Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

INSIGHT
Start date: July 15, 2022
Phase: N/A
Study type: Interventional

This clinical study aims to assess the efficacy of TOTUM-854, a mix of 6 plant extracts, consumed twice a day on automated office blood pressure in subjects with moderately elevated blood pressure. The hypothesis is that TOTUM-854 is superior to placebo for decrease of automated office blood pressure after 12 weeks of consumption.

NCT ID: NCT05397535 Recruiting - Clinical trials for Elevated Blood Pressure

Baduanjin Lower Elevated Blood PreSsure Study

BLESS
Start date: June 5, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effects of Baduanjin on blood pressure in individuals with high normal blood pressure (SBP 130-139 mmHg, and/or DBP 85-89 mmHg), as well as on glucose and lipid metabolism, quality of life, psychology, exercise, immune inflammation, endothelial function, and arterial stiffness.

NCT ID: NCT05370625 Recruiting - Clinical trials for Elevated Blood Pressure

To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

INSIGHT-2
Start date: May 30, 2022
Phase: N/A
Study type: Interventional

The main objective of the study will be to compare the efficacy of a 2.65 g/day dose of TOTUM-854 versus placebo in decreasing SBP in subjects with high-normal blood pressure and Grade I hypertension following 12 weeks of daily intake.